This inventor holds 1 USPTO granted patent. Top assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Takao Iwaguchi: Innovator in Angiogenesis Inhibition
Introduction
Takao Iwaguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis inhibition. His work is crucial for developing therapeutic agents that can help manage conditions such as diabetic retinopathy.
Latest Patents
Iwaguchi holds a patent for a pharmaceutical composition and method for angiogenesis inhibition. The patent describes Actinonin or a salt thereof as an active inhibitor of angiogenesis in mammals. This innovation is particularly useful as a therapeutic agent for inhibiting angiogenesis in mammals suffering from diabetic retinopathy or inflammatory responses accompanied by angiogenesis.
Career Highlights
Iwaguchi is associated with the organization known as Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His work there has focused on advancing research and development in the pharmaceutical sector, contributing to innovative solutions for complex medical issues.
Collaborations
Iwaguchi has collaborated with notable colleagues, including Mariko Shimamura and Shingo Uchida. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Takao Iwaguchi's contributions to the field of angiogenesis inhibition highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for new therapeutic approaches to critical health challenges.